Nav: Home

Tasmanian devil cancer unlikely to cause extinction, say experts

January 23, 2019

A new study of Tasmanian devils has revealed that a transmissible cancer which has devastated devil populations in recent years in unlikely to cause extinction of the iconic species.

New research led by Dr Konstans Wells from Swansea University has revealed that it is more likely that the disease will fade-out or that the devils will coexist with Tasmanian Devil Facial Tumour Disease (DFTD) in future.

DFTD typically kills the majority of devils it infects and has wiped out around 80% of wild devils with continuous decline of existing populations since the disease was first identified.

An international team of scientists from the UK, Australia and the USA matched field epidemiological evidence from wild populations collected over a 10-year period in north-west Tasmania with simulation studies, which revealed that DFTD is unlikely to continue causing ongoing population declines of Tasmanian devils in future.

They say the findings of their study, published in Ecology, offers much-needed hope that the species, which is the world's largest remaining marsupial carnivore, will not necessarily become extinct due to DFTD.

First discovered in north-eastern Tasmania in 1996, DFTD causes tumours to form on the face and neck of the animal. The cancer spreads when the devils bite each other's faces during fighting, thus killing the animals within six to twenty four months.

Dr Konstans Wells, lead author of the study, said: "Our findings suggest that immediate management interventions are unlikely to be necessary to ensure the survival of Tasmanian devil populations. This is because strong population declines of devils after disease emergence do not necessarily translate into long-term population declines".

To explore the long-term outcomes of DFTD and devil populations, the researchers conducted a large number of simulations of possible disease spread in devils. Based on evidence such as current infection rates in the wild, the most likely simulation scenarios were selected to explore how DFTD will affect devil populations over the next 100 years. Among the most likely scenarios were those in which DFTD faded out (57% of likely scenarios) or coexisted with devils (22% of likely scenarios).

Co-author of the study, Dr Rodrigo Hamede from the University of Tasmania, said: "With growing evidence that devils are showing signs of adaptation to DFTD and that so far the disease has not caused local extinctions, management actions targeted at understanding the devil's adaptive strategies to cope with DFTD should be considered.

"Complete eradication of DFTD is not feasible, therefore studying the long-term interactions between devils and tumours will provide a realistic prognosis for the species and at the same time will help us to understand important evolutionary processes. This is particularly relevant given the recent outbreak of a new transmissible cancer - devil facial tumour 2 - affecting devil populations in south-eastern Tasmania. Devils seem to be prone to transmissible cancers, so studying epidemic dynamics and evolutionary responses to this type of diseases should be a priority".

The research suggests that management efforts to maintain devil populations should be guided by the changing understanding of the long-term outcome of the disease impact on devils.

Dr Wells explained: "Management efforts in wild populations that solely aim to combat the impact of DFTD can be counterproductive if they disrupt long-term forces at work that may eventually lead to stable devil populations that are well able to persist with the cancer.

"Wildlife diseases such as DFTD should not disguise the fact that sufficiently large and undisturbed natural environments are a vital prerequisite for wildlife to persist and eventually cope with obstructions such as infectious diseases without human intervention".

The study Individual and temporal variation in pathogen load predicts long-term impacts of an emerging infectious disease is published in Ecology.
-end-


Swansea University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#520 A Closer Look at Objectivism
This week we broach the topic of Objectivism. We'll be speaking with Keith Lockitch, senior fellow at the Ayn Rand Institute, about the philosophy of Objectivism as it's taught through Ayn Rand's writings. Then we'll speak with Denise Cummins, cognitive scientist, author and fellow at the Association for Psychological Science, about the impact of Objectivist ideology on society. Related links: This is what happens when you take Ayn Rand seriously Another Critic Who Doesn’t Care What Rand Thought or Why She Thought It, Only That She’s Wrong Quote is from "A Companion to Ayn Rand"